Citeline：2023年医药研发年度回顾白皮书（52页）.pdf

1、?2023?Citeline Pharmaprojects?Ian Lloyd?2023?4?Pharmaprojects?2023?30?2023?Pharmaprojects?Citeline?1980?1993?31?1813?1984?1949?1951?1969?1859?1874?1869?2023?1?1599?1922?2023?1854?1623?2023?2014?05?2023?07?10?21?37?43?47?5142023?4?2023 Pharma Intelligence UK Limited?Citeline?52023?4?2023 Pharma Intel

2、ligence UK Limited?Citeline?J.R.R.?2023?1?3?4?1?21292?2022?5.89%?8.22%?2021?4.76%?6.90%?1?2001-23?Pharmaprojects?2023?1?20015,00010,00015,00020,00025,000200220032004200520062007200820092010201120122013201420152016201720182019202020212022DRUG COUNT5,9956,1986,4166,9947,3607,4067,7379,6059,7379,71310,

3、45210,47911,30712,30013,71814,87215,26716,18117,73718,5829,21720,109202321,292YEAR62023?4?2023 Pharma Intelligence UK Limited?Citeline?1183?1527?845?2022?Pharmaprojects?5082?2021?6343?2020?4730?5000?12?5082?1183?3899?2022?282?2021?221?3804?4658?2022?40%?40.7%?38.8%?13.5%?19.5%?2021?17.5%?Pfizer?Roch

4、e?2022?1840?1457?2021?(NAS)?97?2020?82?2022?2022?NAS?60?NAS?2022?2021?1938?72023?4?2023 Pharma Intelligence UK Limited?Citeline?2023?Pharmaprojects?2?2023?5.89%?2022?11.0%?4.3%?PreclinPhase IPhase IIPhase IIIPre-regRegisteredLaunchedSuspendedN/ADRUG COUNT11,35111,8352,9473,2632,9223,1311,1191,229231

5、2541701351,2401,29749637985STAGE OF DEVELOPMENT2,0004,0006,0008,00010,00012,00014,00020222023?2?2023?2022?Pharmaprojects?2023?1?-?N/A=?82023?4?2023 Pharma Intelligence UK Limited?Citeline?2023?2023?10.7%?10.1%?2022?6.4%?7.2%?9.8%?8.7%?3?CLINICAL STAGE OF DEVELOPMENTPhase IPhase IIPhase III500DRUG CO

6、UNT1,00015002,0002,5003,0003,500200720082009201020112012201320142015201620172018201920202021202220233,2633,1312,9472,9221,2291,119?3?20072023?Pharmaprojects?2023?1?92023?4?2023 Pharma Intelligence UK Limited?Citeline?2023?(Deloitte Centre for Health Solutions)?2022?2021?6.9?2022?7.09?2021?19.86?2022